According to the New York Times, Johnson & Johnson has pledged to remove a number of potentially harmful chemicals, including formaldehyde, from its line of consumer products by the end of 2015.
Although the company had already pledged to remove certain chemicals from its baby products by 2013, the new announcement extends the program to its adult products. Johnson & Johnson is the first major consumer products company to make such ...
continue reading...
The U.S. Food and Drug administration has ordered St. Jude Medical to do additional studies on patients implanted with medical device components that are blamed in as many as 20 deaths.
According to the New York Times, the FDA has also recommended that patients who received the Riata defibrillator lead — a wire that connects a defibrillator to a patient’s heart — get X-rays or other imaging to check for problems.
The ...
continue reading...
According to the Mayo Clinic, many health care providers can treat bladder control problems without referring you to a specialist.
But not all primary care providers have the necessary training or experience. And despite the current improved understanding and treatment of urinary incontinence, some doctors consider it an inevitable consequence of childbearing, menopause or normal aging. That belief may make them unlikely to consider treatment.
Another factor to be wary of is ...
continue reading...According to a story in the New York Times, a renewed U.S. Justice Department emphasis on prosecuting corporate fraud is expected to bring in as much as $8 billion this year from pharmaceutical companies, military contractors, banks and other corporations charged with defrauding the government, which amounts to a record sum.
Still, the lack of charges against executives at those companies is resurrecting questions about accountability, and just how much of ...
continue reading...A prominent Wall Street analyst is suggesting that the best way for Johnson & Johnson to cope with its many problems would be to break into smaller companies, according to an article in the Asbury Park Press.
Jami Rubin of Goldman Sachs suggests that splitting Johnson & Johnson’s three divisions into separate companies would free up money to invest, help the company grow faster and provide a bigger return to shareholders.
The ...
continue reading...
Johnson & Johnson’s Synthes unit, a maker of tools and implants to treat damaged bones, has been sued by the family of a woman who died during an unapproved trial of a bone cement, Bloomberg reports.
It’s an ironic development for Johnson & Johnson, which recently purchased Synthes for $19.7 billion, largely in the hopes it would help offset revenue losses related to a series of recalls and legal problems over ...
continue reading...
